PMC:7461420 / 31361-31721 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T172","span":{"begin":264,"end":269},"obj":"Body_part"}],"attributes":[{"id":"A172","pred":"fma_id","subj":"T172","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"A similar approach has been investigated to prevent viral entry of SARS‐CoV‐2. Pöhlmann et al. reported the attainment of full inhibition efficiency with a combination of both 18 and E‐64d (a cathepsin inhibitor). Both studies indicate that SARS‐CoV‐1 and 2 enter cells in a similar manner showing the potential of 18 as a candidate for further development. 15"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T179","span":{"begin":67,"end":71},"obj":"Disease"},{"id":"T180","span":{"begin":241,"end":245},"obj":"Disease"}],"attributes":[{"id":"A179","pred":"mondo_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A180","pred":"mondo_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"A similar approach has been investigated to prevent viral entry of SARS‐CoV‐2. Pöhlmann et al. reported the attainment of full inhibition efficiency with a combination of both 18 and E‐64d (a cathepsin inhibitor). Both studies indicate that SARS‐CoV‐1 and 2 enter cells in a similar manner showing the potential of 18 as a candidate for further development. 15"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T355","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T356","span":{"begin":19,"end":22},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T357","span":{"begin":154,"end":155},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T358","span":{"begin":176,"end":178},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T359","span":{"begin":190,"end":191},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T360","span":{"begin":264,"end":269},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T361","span":{"begin":273,"end":274},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T362","span":{"begin":315,"end":317},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T363","span":{"begin":321,"end":322},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"A similar approach has been investigated to prevent viral entry of SARS‐CoV‐2. Pöhlmann et al. reported the attainment of full inhibition efficiency with a combination of both 18 and E‐64d (a cathepsin inhibitor). Both studies indicate that SARS‐CoV‐1 and 2 enter cells in a similar manner showing the potential of 18 as a candidate for further development. 15"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T281","span":{"begin":202,"end":211},"obj":"Chemical"}],"attributes":[{"id":"A281","pred":"chebi_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"A similar approach has been investigated to prevent viral entry of SARS‐CoV‐2. Pöhlmann et al. reported the attainment of full inhibition efficiency with a combination of both 18 and E‐64d (a cathepsin inhibitor). Both studies indicate that SARS‐CoV‐1 and 2 enter cells in a similar manner showing the potential of 18 as a candidate for further development. 15"}

{"project":"LitCovid-PubTator","denotations":[{"id":"994","span":{"begin":67,"end":77},"obj":"Species"},{"id":"995","span":{"begin":241,"end":249},"obj":"Species"},{"id":"996","span":{"begin":190,"end":211},"obj":"Gene"},{"id":"997","span":{"begin":183,"end":188},"obj":"Chemical"}],"attributes":[{"id":"A994","pred":"tao:has_database_id","subj":"994","obj":"Tax:2697049"},{"id":"A995","pred":"tao:has_database_id","subj":"995","obj":"Tax:694009"},{"id":"A996","pred":"tao:has_database_id","subj":"996","obj":"Gene:6783"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A similar approach has been investigated to prevent viral entry of SARS‐CoV‐2. Pöhlmann et al. reported the attainment of full inhibition efficiency with a combination of both 18 and E‐64d (a cathepsin inhibitor). Both studies indicate that SARS‐CoV‐1 and 2 enter cells in a similar manner showing the potential of 18 as a candidate for further development. 15"}

{"project":"LitCovid-sentences","denotations":[{"id":"T292","span":{"begin":79,"end":213},"obj":"Sentence"},{"id":"T293","span":{"begin":214,"end":357},"obj":"Sentence"},{"id":"T294","span":{"begin":358,"end":360},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A similar approach has been investigated to prevent viral entry of SARS‐CoV‐2. Pöhlmann et al. reported the attainment of full inhibition efficiency with a combination of both 18 and E‐64d (a cathepsin inhibitor). Both studies indicate that SARS‐CoV‐1 and 2 enter cells in a similar manner showing the potential of 18 as a candidate for further development. 15"}